» Articles » PMID: 16961601

Preliminary Laboratory Based Diagnostic Criteria for Immune Thrombocytopenic Purpura: Evaluation by Multi-center Prospective Study

Overview
Publisher Elsevier
Specialty Hematology
Date 2006 Sep 12
PMID 16961601
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: We proposed diagnostic criteria for immune thrombocytopenic purpura (ITP) by modifying the existing guidelines for diagnosis of ITP and by incorporating laboratory tests found useful for predicting its diagnosis, for example erythrocyte count, leukocyte count, anti-GPIIb/IIIa antibody-producing B cells, platelet-associated anti-GPIIb/IIIa antibodies, percentage of reticulated platelets, and plasma thrombopoietin.

Objective And Methods: To validate our criteria, we conducted a multi-center prospective study involving 112 patients with thrombocytopenia and a morphologically normal peripheral blood film at the first visit. Each patient underwent a physical examination, routine laboratory tests, and specialized tests for the anti-GPIIb/IIIa antibody response and platelet turnover.

Results: Ninety-one patients (81%) satisfied the proposed criteria at first visit. Clinical diagnosis was made by skilled hematologists > 6 months after the first visit; ITP was diagnosed in 88 patients and non-ITP disorders in 24. The proposed criteria had 98% sensitivity, 79% specificity, a 95% positive predictive value, and a 90% negative predictive value. A relatively low specificity appears to be attributed to a few patients who had both ITP and aplastic anemia or myelodysplastic syndrome.

Conclusions: Our preliminary diagnostic criteria based on ITP-associated laboratory findings were useful for the differential diagnosis of ITP, but additional evaluations and modifications will be necessary to develop criteria that can be used routinely.

Citing Articles

A prospective cohort study to identify clinical diagnostic and prognostic markers of primary immune thrombocytopenia in dogs.

Brooks M, Goggs R, Frye A, Armato J, Forman M, Hertl J J Vet Intern Med. 2024; 38(2):1022-1034.

PMID: 38205735 PMC: 10937499. DOI: 10.1111/jvim.16985.


Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.

Kashiwagi H, Kuwana M, Murata M, Shimada N, Takafuta T, Yamanouchi J Int J Hematol. 2023; 119(1):1-13.

PMID: 37957517 PMC: 10770234. DOI: 10.1007/s12185-023-03672-1.


[Efficacy of decitabine in patients with glucocorticoid-resistant primary immune thrombocytopenia: factors influencing treatment responses].

Yang J, Xue M, Zhang X, Wei Z, Shao L, Shi Y Zhonghua Xue Ye Xue Za Zhi. 2023; 44(7):567-571.

PMID: 37749037 PMC: 10509621. DOI: 10.3760/cma.j.issn.0253-2727.2023.07.008.


Utility of indium-111 platelet scintigraphy for understanding the mechanism of thrombocytopenia associated with myelodysplastic syndromes and chronic myelomonocytic leukemia.

Durand P, Pottier V, Mesguich C, Debordeaux F, Lazaro E, Viallard J Exp Hematol Oncol. 2023; 12(1):50.

PMID: 37254182 PMC: 10228125. DOI: 10.1186/s40164-023-00414-1.


Development of an Automated Chemiluminescent Enzyme Immunoassay for Measuring Thrombopoietin in Human Plasma.

Nishikawa Y, Nishida S, Kuroda K, Kashiwagi H, Tomiyama Y, Kuwana M Diagnostics (Basel). 2022; 12(2).

PMID: 35204403 PMC: 8871323. DOI: 10.3390/diagnostics12020313.